' 
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
6.8
USERS' SCORE
Very Good
Based on 205 Reviews
8.9
Supplement Facts
Serving Size: 2 Softgels
Amount Per Serving
%DV
Calories
20
Total Fat
2 g
3%**
Saturated Fat
0.5 g
3%**
Polyunsaturated Fat
1 g
†
Monounsaturated Fat
0.5 g
†
Fish Oil Concentrate
2 g (2,000 mg)
†
Eicosapentaenoic Acid (EPA)
360 mg
†
Docosahexaenoic Acid (DHA)
240 mg
†
Top Medical Research Studies
9
Omega-3 lowers coronary risk
A Bayesian Analysis of the VITAL Trial: Effects of Omega-3 Fatty Acid Supplementation on Cardiovascular Events.
Directly related to heart disease
We explored the impact of eicosapentaenoic acid (EPA), a type of omega-3 fatty acid, on heart disease through a significant study known as the VITAL trial. This study involved nearly 26,000 older adults in the U.S. and aimed to determine the effects of daily EPA supplementation on cardiovascular events over an average follow-up of 5.3 years.
Initially, the results from VITAL seemed to show that omega-3 supplementation had no significant effect on major cardiovascular disease (CVD) events. However, by applying Bayesian methods and considering prior research in the field, we observed a more nuanced outcome. Our analysis suggested that taking EPA regularly could significantly reduce the risk of coronary heart disease events, while not showing similar benefits for stroke.
This finding supports the use of omega-3 fatty acids as a preventive measure for heart health, especially regarding coronary events. Although we didn't find evidence of a benefit for all types of cardiovascular events, the enhanced understanding gained from this reanalysis contributes valuable insights for both clinicians and patients considering omega-3 supplementation for heart disease prevention.
Initially, the results from VITAL seemed to show that omega-3 supplementation had no significant effect on major cardiovascular disease (CVD) events. However, by applying Bayesian methods and considering prior research in the field, we observed a more nuanced outcome. Our analysis suggested that taking EPA regularly could significantly reduce the risk of coronary heart disease events, while not showing similar benefits for stroke.
This finding supports the use of omega-3 fatty acids as a preventive measure for heart health, especially regarding coronary events. Although we didn't find evidence of a benefit for all types of cardiovascular events, the enhanced understanding gained from this reanalysis contributes valuable insights for both clinicians and patients considering omega-3 supplementation for heart disease prevention.
Read More
9
EPA helps fight heart disease
Eicosapentaenoic acid induces macrophage Mox polarization to prevent diabetic cardiomyopathy.
Strong evidence of EPA's benefits
We explored the effects of eicosapentaenoic acid (EPA) on heart disease, particularly diabetic cardiomyopathy (DC). This condition is a significant cause of heart failure, yet until now, effective treatment options have been limited. Our study focused on the protective role of EPA in diabetic mice induced by streptozotocin and high-fat diets.
Our findings indicate that EPA is beneficial in reducing the harmful M1-polarized macrophages in the heart. In laboratory tests, EPA showed the ability to protect heart cells from damage caused by these inflammatory cells by shifting the macrophage type from M1 to Mox, rather than to the M2 type. This is crucial since Mox polarization can help shield heart cells from the adverse effects of M1 macrophages.
Additionally, we discovered that a protein called heme oxygenase 1 (HO-1) plays a crucial role in sustaining this protective Mox phenotype. EPA promotes HO-1 levels, which in turn helps reduce M1 polarization and its damaging effects on heart cells. Even more promising, EPA was shown to enhance Mox polarization in macrophages derived from diabetic patients, indicating its potential as a treatment strategy.
Overall, our research highlights EPA and macrophage Mox polarization as innovative approaches to combat diabetic cardiomyopathy, showcasing a new avenue in the fight against heart disease.
Our findings indicate that EPA is beneficial in reducing the harmful M1-polarized macrophages in the heart. In laboratory tests, EPA showed the ability to protect heart cells from damage caused by these inflammatory cells by shifting the macrophage type from M1 to Mox, rather than to the M2 type. This is crucial since Mox polarization can help shield heart cells from the adverse effects of M1 macrophages.
Additionally, we discovered that a protein called heme oxygenase 1 (HO-1) plays a crucial role in sustaining this protective Mox phenotype. EPA promotes HO-1 levels, which in turn helps reduce M1 polarization and its damaging effects on heart cells. Even more promising, EPA was shown to enhance Mox polarization in macrophages derived from diabetic patients, indicating its potential as a treatment strategy.
Overall, our research highlights EPA and macrophage Mox polarization as innovative approaches to combat diabetic cardiomyopathy, showcasing a new avenue in the fight against heart disease.
Read More
8
Eicosapentaenoic Acid reduces heart risks
Omega-3 Fatty Acids as Potential Predictors of Sudden Cardiac Death and Cardiovascular Mortality: A Systematic Review and Meta-Analysis.
High relevance to heart health
We evaluated the impact of eicosapentaenoic acid (EPA) on heart disease, specifically focusing on its potential to reduce the risk of sudden cardiac death (SCD) and cardiovascular mortality (CVD mortality). Through a systematic review and meta-analysis, we gathered insights from 10 prospective cohort studies involving a total of 310,955 participants over an average follow-up period of 8.7 years.
Our analysis revealed that higher levels of omega-3 fatty acids, including EPA, in the blood were associated with a lower risk of both SCD and CVD mortality. Specifically, we found that individuals with high circulating levels of EPA and other omega-3s had a significantly reduced hazard ratio of 0.55 for SCD compared to those with lower levels. This suggests a protective effect linked to increased EPA intake.
Furthermore, our sub-analysis indicated that higher percentages of EPA and another omega-3 called DHA in the blood also correlated with a reduced risk of adverse cardiac events. These findings highlight the promising role of EPA as a beneficial component in cardiovascular health strategies.
Overall, the evidence suggests that increasing our intake of EPA could serve as an effective measure to lessen the incidence of serious heart-related issues, making it a topic worth considering in future dietary recommendations.
Our analysis revealed that higher levels of omega-3 fatty acids, including EPA, in the blood were associated with a lower risk of both SCD and CVD mortality. Specifically, we found that individuals with high circulating levels of EPA and other omega-3s had a significantly reduced hazard ratio of 0.55 for SCD compared to those with lower levels. This suggests a protective effect linked to increased EPA intake.
Furthermore, our sub-analysis indicated that higher percentages of EPA and another omega-3 called DHA in the blood also correlated with a reduced risk of adverse cardiac events. These findings highlight the promising role of EPA as a beneficial component in cardiovascular health strategies.
Overall, the evidence suggests that increasing our intake of EPA could serve as an effective measure to lessen the incidence of serious heart-related issues, making it a topic worth considering in future dietary recommendations.
Read More
Most Useful Reviews
8.8
Improved heart health
Quality product! This fish oil is excellent for health conscious individuals. It provides a good dose of fatty acids and comes from a reputable manufacturer. At 32, I take these capsules for my hair and skin. After various diets, fish oil has been a saviour: my skin is supple, and my hair is less damaged. My parents ordered it for heart disease; my mother, 55, noticed improvement in energy and skin condition. I recommend this product, taking 2 capsules 1-3 times daily with meals. The large capsules are easy to swallow.
Read More
9.5
Heart health improvement
I've been taking this with lecithin, and my heart problems have disappeared, leading to better sleep. At my age (81), staying healthy is crucial; illness disrupts my plans. Given my family's history of longevity, I aim to remain active for my children and grandchildren. I choose Omega-3 and highly recommend it!
Read More
9.5
Women's health boost
The quality is superb, and there are no age restrictions. This Omega 3 is vital for women’s health, notably improving hair condition. It reduces cholesterol and relieves inflammation. I recommend it, especially for heart disease.
Read More
Most Recommended Products for Heart Disease
Solaray Timed Release Vitamin C with Rose Hips & Acerola
SCIENTIFIC SCORE
No researches found
N/A
USERS' SCORE
Excellent
Based on 1 Reviews
9.5
NOW Foods Solutions
SCIENTIFIC SCORE
No researches found
N/A
USERS' SCORE
Excellent
Based on 1 Reviews
9.5
American Health Ester-C with Citrus Bioflavonoids
SCIENTIFIC SCORE
No researches found
N/A
USERS' SCORE
Excellent
Based on 2 Reviews
9.2
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
6.8
9
Omega-3 lowers coronary risk
A Bayesian Analysis of the VITAL Trial: Effects of Omega-3 Fatty Acid Supplementation on Cardiovascular Events.
Directly related to heart disease
We explored the impact of eicosapentaenoic acid (EPA), a type of omega-3 fatty acid, on heart disease through a significant study known as the VITAL trial. This study involved nearly 26,000 older adults in the U.S. and aimed to determine the effects of daily EPA supplementation on cardiovascular events over an average follow-up of 5.3 years.
Initially, the results from VITAL seemed to show that omega-3 supplementation had no significant effect on major cardiovascular disease (CVD) events. However, by applying Bayesian methods and considering prior research in the field, we observed a more nuanced outcome. Our analysis suggested that taking EPA regularly could significantly reduce the risk of coronary heart disease events, while not showing similar benefits for stroke.
This finding supports the use of omega-3 fatty acids as a preventive measure for heart health, especially regarding coronary events. Although we didn't find evidence of a benefit for all types of cardiovascular events, the enhanced understanding gained from this reanalysis contributes valuable insights for both clinicians and patients considering omega-3 supplementation for heart disease prevention.
Initially, the results from VITAL seemed to show that omega-3 supplementation had no significant effect on major cardiovascular disease (CVD) events. However, by applying Bayesian methods and considering prior research in the field, we observed a more nuanced outcome. Our analysis suggested that taking EPA regularly could significantly reduce the risk of coronary heart disease events, while not showing similar benefits for stroke.
This finding supports the use of omega-3 fatty acids as a preventive measure for heart health, especially regarding coronary events. Although we didn't find evidence of a benefit for all types of cardiovascular events, the enhanced understanding gained from this reanalysis contributes valuable insights for both clinicians and patients considering omega-3 supplementation for heart disease prevention.
Read More
9
Eicosapentaenoic acid improves heart function
The Optimal Dosage and Duration of ω-3 PUFA Supplementation in Heart Failure Management: Evidence from a Network Meta-Analysis.
Directly studies heart failure treatment
We explored how eicosapentaenoic acid (a type of omega-3 fatty acid) can play a role in improving heart health, particularly in individuals with heart failure. Our analysis involved a network meta-analysis of numerous randomized controlled trials, focusing on the effects of eicosapentaenoic acid on heart function.
The findings showed that high doses of omega-3 supplements, specifically between 2000 to 4000 mg per day, taken for at least a year, can significantly enhance left ventricular ejection fraction, which is an important measure of heart function. This is encouraging news for patients struggling with heart failure, as a better ejection fraction can lead to improved heart health.
We also observed improvements in peak oxygen consumption, offering further evidence of how eicosapentaenoic acid can boost cardiac performance. Importantly, we found no significant increases in dropout rates or overall mortality among those taking omega-3 supplements compared to those not taking them. This suggests that the benefits come without added risks.
Overall, our research underscores the potential of long-term, high-dose eicosapentaenoic acid supplementation as a supportive treatment option for heart failure patients, advocating for further studies to confirm these promising results and help refine treatment recommendations.
The findings showed that high doses of omega-3 supplements, specifically between 2000 to 4000 mg per day, taken for at least a year, can significantly enhance left ventricular ejection fraction, which is an important measure of heart function. This is encouraging news for patients struggling with heart failure, as a better ejection fraction can lead to improved heart health.
We also observed improvements in peak oxygen consumption, offering further evidence of how eicosapentaenoic acid can boost cardiac performance. Importantly, we found no significant increases in dropout rates or overall mortality among those taking omega-3 supplements compared to those not taking them. This suggests that the benefits come without added risks.
Overall, our research underscores the potential of long-term, high-dose eicosapentaenoic acid supplementation as a supportive treatment option for heart failure patients, advocating for further studies to confirm these promising results and help refine treatment recommendations.
Read More
9
EPA helps fight heart disease
Eicosapentaenoic acid induces macrophage Mox polarization to prevent diabetic cardiomyopathy.
Strong evidence of EPA's benefits
We explored the effects of eicosapentaenoic acid (EPA) on heart disease, particularly diabetic cardiomyopathy (DC). This condition is a significant cause of heart failure, yet until now, effective treatment options have been limited. Our study focused on the protective role of EPA in diabetic mice induced by streptozotocin and high-fat diets.
Our findings indicate that EPA is beneficial in reducing the harmful M1-polarized macrophages in the heart. In laboratory tests, EPA showed the ability to protect heart cells from damage caused by these inflammatory cells by shifting the macrophage type from M1 to Mox, rather than to the M2 type. This is crucial since Mox polarization can help shield heart cells from the adverse effects of M1 macrophages.
Additionally, we discovered that a protein called heme oxygenase 1 (HO-1) plays a crucial role in sustaining this protective Mox phenotype. EPA promotes HO-1 levels, which in turn helps reduce M1 polarization and its damaging effects on heart cells. Even more promising, EPA was shown to enhance Mox polarization in macrophages derived from diabetic patients, indicating its potential as a treatment strategy.
Overall, our research highlights EPA and macrophage Mox polarization as innovative approaches to combat diabetic cardiomyopathy, showcasing a new avenue in the fight against heart disease.
Our findings indicate that EPA is beneficial in reducing the harmful M1-polarized macrophages in the heart. In laboratory tests, EPA showed the ability to protect heart cells from damage caused by these inflammatory cells by shifting the macrophage type from M1 to Mox, rather than to the M2 type. This is crucial since Mox polarization can help shield heart cells from the adverse effects of M1 macrophages.
Additionally, we discovered that a protein called heme oxygenase 1 (HO-1) plays a crucial role in sustaining this protective Mox phenotype. EPA promotes HO-1 levels, which in turn helps reduce M1 polarization and its damaging effects on heart cells. Even more promising, EPA was shown to enhance Mox polarization in macrophages derived from diabetic patients, indicating its potential as a treatment strategy.
Overall, our research highlights EPA and macrophage Mox polarization as innovative approaches to combat diabetic cardiomyopathy, showcasing a new avenue in the fight against heart disease.
Read More
9
Omega-3s and heart disease risk
Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies.
Considered broader omega-3 impacts
We explored the connection between omega-3 fatty acids, particularly eicosapentaenoic acid (EPA), and coronary heart disease (CHD). Our analysis reviewed 36 observational studies that included both prospective and retrospective designs, offering a well-rounded look at how different omega-3 levels may impact heart health.
The results highlighted a clear trend: higher levels of various omega-3 fatty acids, including EPA, were associated with a reduced risk of developing CHD. We noted that groups with elevated omega-3 levels displayed lower relative risks—indicating that maintaining a sufficient intake of these fatty acids could be beneficial for heart health.
Interestingly, our findings revealed that patients with CHD had significantly lower omega-3 levels compared to healthier individuals. Moreover, specific subtypes of omega-3, such as EPA and DHA, demonstrated a particularly strong inverse relationship with both fatal and non-fatal heart disease events.
Overall, this analysis shows that omega-3 polyunsaturated fatty acids, especially EPA and DHA, are linked to a decreased risk of CHD. Our findings support the idea that integrating these nutrients into our diets may provide protective benefits against heart disease.
The results highlighted a clear trend: higher levels of various omega-3 fatty acids, including EPA, were associated with a reduced risk of developing CHD. We noted that groups with elevated omega-3 levels displayed lower relative risks—indicating that maintaining a sufficient intake of these fatty acids could be beneficial for heart health.
Interestingly, our findings revealed that patients with CHD had significantly lower omega-3 levels compared to healthier individuals. Moreover, specific subtypes of omega-3, such as EPA and DHA, demonstrated a particularly strong inverse relationship with both fatal and non-fatal heart disease events.
Overall, this analysis shows that omega-3 polyunsaturated fatty acids, especially EPA and DHA, are linked to a decreased risk of CHD. Our findings support the idea that integrating these nutrients into our diets may provide protective benefits against heart disease.
Read More
8
Cardiovascular benefits of eicosapentaenoic acid
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial.
Study considers statin-treated patients
We explored the effectiveness of icosapent ethyl, a formulation of eicosapentaenoic acid, in reducing cardiovascular risks among patients who were already on statin therapy. The focus was on individuals with elevated triglyceride levels and low-density lipoprotein cholesterol (LDL-C) at a baseline of 41 to 100 mg/dL.
In this comprehensive analysis of the REDUCE-IT trial, we observed that patients were randomly assigned to receive either icosapent ethyl or a placebo, allowing for a clear comparison of results. The findings revealed that even those with well-controlled LDL-C levels, categorized as less than 55 mg/dL, exhibited significant benefits in cardiovascular outcomes when treated with icosapent ethyl.
Specifically, patients with LDL-C below 55 mg/dL experienced a notable reduction in primary cardiovascular events, with a reported decrease in rates from 22.8% to 16.2%. We also found similar outcomes in patients with LDL-C of 55 mg/dL or higher, further emphasizing the drug's potential effectiveness across different baseline cholesterol levels.
Overall, the study suggests that icosapent ethyl can confer cardiovascular benefits regardless of a patient's baseline LDL-C, indicating its importance in heart disease management, particularly for those at high cardiovascular risk.
In this comprehensive analysis of the REDUCE-IT trial, we observed that patients were randomly assigned to receive either icosapent ethyl or a placebo, allowing for a clear comparison of results. The findings revealed that even those with well-controlled LDL-C levels, categorized as less than 55 mg/dL, exhibited significant benefits in cardiovascular outcomes when treated with icosapent ethyl.
Specifically, patients with LDL-C below 55 mg/dL experienced a notable reduction in primary cardiovascular events, with a reported decrease in rates from 22.8% to 16.2%. We also found similar outcomes in patients with LDL-C of 55 mg/dL or higher, further emphasizing the drug's potential effectiveness across different baseline cholesterol levels.
Overall, the study suggests that icosapent ethyl can confer cardiovascular benefits regardless of a patient's baseline LDL-C, indicating its importance in heart disease management, particularly for those at high cardiovascular risk.
Read More
User Reviews
USERS' SCORE
Very Good
Based on 205 Reviews
8.9
10
Cancer prevention
Omega-3 contains essential fatty acids that lower cholesterol, preventing heart disease and atherosclerosis. Studies show it slows tumour development and aids in various health issues. It’s beneficial for joint pain and normal brain function. I recommend taking three capsules daily with meals to enjoy these extensive health benefits, including heart health.
Read More
9.5
Heart health improvement
I've been taking this with lecithin, and my heart problems have disappeared, leading to better sleep. At my age (81), staying healthy is crucial; illness disrupts my plans. Given my family's history of longevity, I aim to remain active for my children and grandchildren. I choose Omega-3 and highly recommend it!
Read More
9.5
Excellent heart support
This Omega 3 is wonderful for numerous reasons: price, taste, and product quality. It yields great results, benefiting my hair and heart while reducing inflammation. The convenient packaging, ample useful ingredients, and natural components make it an excellent choice for health. No issues at all; I wholeheartedly recommend it to everyone.
Read More
9.5
Heart health support
These Omega 3 fatty acids are superb for many reasons: price, fantastic taste, and high quality. They've positively impacted my hair and heart, reduced inflammation, and normalised my cholesterol. The natural ingredients and excellent packaging make this product ideal. I recommend it to everyone; no problems experienced.
Read More
9.5
Heart resilience boost
This Omega 3 is fantastic for a variety of reasons: price, taste, and quality of the product. My hair has become stronger, and my heart is more resilient. It also contains many beneficial substances, packaged conveniently. I fully endorse this wonderful product as it meets expectations impeccably.
Read More
